 | Up a level |
Borradori, L; Van Beek, N; Feliciani, C; Tedbirt, B; Antiga, E; Bergman, R; Böckle, B C; Caproni, M; Caux, F; Chandran, N S; Cianchini, G; Daneshpazhooh, M; De, D; Didona, D; Di Zenzo, G M; Dmochowski, M; Drenovska, K; Ehrchen, J; Goebeler, M; Groves, R; ... (2022). Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology and Venereology : JEADV, 36(10), pp. 1689-1704. Wiley 10.1111/jdv.18220
Rashid, H; Lamberts, A; Borradori, L; Alberti-Violetti, S; Barry, R J; Caproni, M; Carey, B; Carrozzo, M; Caux, F; Cianchini, G; Corrà, A; Diercks, G F H; Dikkers, F G; Di Zenzo, G; Feliciani, C; Geerling, G; Genovese, G; Hertl, M; Joly, P; Marzano, A V; ... (2021). European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(9), pp. 1750-1764. Wiley 10.1111/jdv.17397
Joly, P; Horwath, B; Patsatsi, Α; Uzun, S; Bech, R; Beissert, S; Bergman, R; Bernard, P; Borradori, L.; Caproni, M; Caux, F; Cianchini, G; Daneshpazhooh, M; De, D; Dmochowski, M; Drenovska, K; Ehrchen, J; Feliciani, C; Goebeler, M; Groves, R; ... (2020). Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). Journal of the European Academy of Dermatology and Venereology : JEADV, 34(9), pp. 1900-1913. Wiley 10.1111/jdv.16752
Boulard, C; Duvert Lehembre, S; Picard-Dahan, C; Kern, J S; Zambruno, G; Feliciani, C; Marinovic, B; Vabres, P; Borradori, Luca; Prost-Squarcioni, C; Labeille, B; Richard, M A; Ingen-Housz-Oro, S; Houivet, E; Werth, V P; Murrell, D F; Hertl, M; Benichou, J; Joly, P (2016). Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus. British journal of dermatology, 175(1), pp. 142-149. Wiley 10.1111/bjd.14405
Kolios, A G A; Maul, J-T; Meier, B; Kerl, K; Traidl-Hoffmann, C; Hertl, M; Zillikens, D; Röcken, M; Ring, J; Facchiano, A; Mondino, C; Yawalkar, Nikhil; Contassot, E; Navarini, A A; French, L E (2015). Canakinumab in adults with steroid-refractory pyoderma gangrenosum. British journal of dermatology, 173(5), pp. 1216-1223. Wiley-Blackwell 10.1111/bjd.14037
Feliciani, C; Joly, P; Jonkman, M F; Zambruno, G; Zillikens, D; Ioannides, D; Kowalewski, C; Jedlickova, H; Kárpáti, S; Marinovic, B; Mimouni, D; Uzun, S; Yayli, S; Hertl, M; Borradori, Luca (2015). Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. British journal of dermatology, 172(4), pp. 867-877. Wiley-Blackwell 10.1111/bjd.13717
Hertl, M; Jedlickova, H; Karpati, S; Marinovic, B; Uzun, S; Yayli, S; Mimouni, D; Borradori, Luca; Feliciani, C; Ioannides, D; Joly, P; Kowalewski, C; Zambruno, G; Zillikens, D; Jonkman, M F (2015). Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology and Venereology, 29(3), pp. 405-414. Blackwell 10.1111/jdv.12772
Hertl, M; Niedermeier, A; Borradori, L (2010). Autoimmune bullous skin disorders. Therapeutische Umschau, 67(9), pp. 465-482. Bern: Huber 10.1515/CCLM.2006.027
